Opportunity Information: Apply for PAR 11 079
Apply for PAR 11 079
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Cancer Prevention Research Small Grant Program (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research.
- This funding opportunity was created on Dec 13, 2010 and posted on Dec 13, 2010.
- Applicants must submit their applications by Dec 16, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses State governments Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) Private institutions of higher education County governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Independent school districts.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Cancer Prevention Research Small Grant Program (R03), Funding Opportunity Number PAR-11-079, is a National Institutes of Health (NIH) grant opportunity administered through the National Cancer Institute (NCI). It supports small, time-limited research projects aimed at strengthening the cancer prevention pipeline, with an emphasis on generating early evidence that can later be expanded into larger, full-scale research project grants. The FOA is positioned as a practical entry point for testing novel ideas, collecting preliminary data, and running feasibility or pilot studies that directly contribute to preventing cancer or detecting it earlier.
The scientific scope is centered on cancer prevention rather than treatment. NCI is looking for projects that advance the development of cancer chemoprevention agents (substances intended to reduce cancer risk), improve or validate biomarkers for early detection, deepen cancer-related nutrition science, and conduct clinical prevention studies that focus on specific target organs. The FOA allows a range of research approaches, including basic animal studies, translational work that bridges laboratory findings to human applications, and human-subjects research when appropriate. The underlying theme is practical prevention impact: projects should move the field toward strategies, tools, or interventions that can reduce incidence or identify disease earlier when outcomes are typically better.
At the same time, the announcement draws clear boundaries around what does not fit. Applications focused on treatment are not appropriate, and neither are projects primarily about cancer etiology (basic causes or origins of cancer), metastasis, or the development of animal models as an end in itself. It also excludes treatment-related quality of life population-based studies, which often sit closer to cancer care delivery than prevention. In other words, this FOA is not meant to fund oncology therapeutics, survivorship-focused quality of life research tied to treatment, or foundational model-building work unless it is tightly tied to the stated prevention objectives.
The program is open to both new and established investigators and encourages participation from a wide mix of relevant disciplines. Examples highlighted include chemoprevention, nutritional science, genetics, infectious agents, and early detection research, including biomarker development and validation. The intent is to lower the barrier for investigators who have promising, innovative prevention concepts but need a modest amount of support to demonstrate feasibility, refine methods, or produce the early data required to compete for larger NIH mechanisms later.
In terms of administrative details, the opportunity is categorized as discretionary funding and uses the grant funding instrument. It falls under the health-related funding activity category and is associated with CFDA 93.393, Cancer Cause and Prevention Research. The FOA does not require cost sharing or matching, which is important for applicants planning budgets and institutional commitments. The opportunity was posted and created on December 13, 2010, with an original and current closing date of December 16, 2013, and it was archived on January 16, 2014, meaning it is no longer active as listed in this specific announcement.
Eligibility is broad and includes many organization types, reflecting NIH's typical openness to diverse research institutions and community-linked entities. Eligible applicants include public and private institutions of higher education, nonprofits (including 501(c)(3) organizations), for-profit organizations (including small businesses and other for-profits), and multiple levels of government such as state, county, city/township, special district governments, and certain housing authorities. It also includes Native American tribal governments (federally recognized) and tribal organizations, as well as independent school districts. Additional eligible groups mentioned include Alaska Native and Native Hawaiian Serving Institutions, Hispanic-Serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This wide eligibility signals that NCI is interested in prevention research capacity wherever it exists, including institutions that serve underrepresented populations or operate in community settings where prevention and early detection research can be especially meaningful.
For applicants seeking the full text and application specifics, the FOA points to the NIH Grants Guide page for PAR-11-079 at http://grants.nih.gov/grants/guide/pa-files/PAR-11-079.html. For technical access issues, NIH lists the Office of Extramural Research (OER) Webmaster contact at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs): Cancer Prevention Research Small Grant Program (R03) - PAR-11-079
What is PAR-11-079 (Cancer Prevention Research Small Grant Program R03)?
PAR-11-079 is a National Institutes of Health (NIH) funding opportunity administered through the National Cancer Institute (NCI) for the Cancer Prevention Research Small Grant Program (R03). It supports small, time-limited research projects designed to strengthen the cancer prevention research pipeline, especially by generating early evidence that can be expanded later into larger, full-scale research grants.
Which NIH institute administers this funding opportunity?
This grant opportunity is administered by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH).
What is the main purpose of this R03 small grant program?
The primary purpose is to fund practical, early-stage cancer prevention research that helps investigators test novel ideas, collect preliminary data, and conduct feasibility or pilot studies. The intention is to produce early evidence that positions a project for later expansion into larger NIH research project grant mechanisms.
Is this opportunity focused on cancer prevention or cancer treatment?
This opportunity is focused on cancer prevention rather than treatment. Projects should directly contribute to preventing cancer or detecting it earlier.
What kinds of research topics are within the scientific scope of this FOA?
The scope centers on cancer prevention and early detection. Examples of areas specifically described include development of cancer chemoprevention agents, improvement or validation of biomarkers for early detection, cancer-related nutrition science, and clinical prevention studies that focus on specific target organs.
Does this FOA support biomarker research?
Yes. The FOA highlights early detection research, including biomarker development and validation, as within scope, particularly when the work advances earlier cancer detection.
Does this FOA support chemoprevention research?
Yes. NCI is looking for projects that advance the development of cancer chemoprevention agents, meaning substances intended to reduce cancer risk.
Does this FOA support nutrition-focused cancer prevention research?
Yes. The FOA explicitly mentions deepening cancer-related nutrition science as part of its prevention-oriented scientific scope.
Does this FOA support clinical prevention studies?
Yes. The FOA includes clinical prevention studies, including those that focus on specific target organs, as within scope.
What types of research approaches are allowed under this FOA?
The FOA allows a range of approaches, including basic animal studies, translational research that bridges laboratory findings to human applications, and human-subjects research when appropriate, as long as the work is aligned with cancer prevention and/or earlier detection.
What is the overall theme NCI is looking for in proposed projects?
The underlying theme is practical prevention impact. Projects should move the field toward strategies, tools, or interventions that can reduce cancer incidence or identify disease earlier, when outcomes are typically better.
What types of projects are specifically not appropriate for this FOA?
The FOA states that applications focused on treatment are not appropriate. It also excludes projects primarily about cancer etiology (basic causes or origins of cancer), metastasis, or the development of animal models as an end in itself. In addition, it excludes treatment-related quality of life population-based studies.
Are oncology therapeutics or treatment-focused studies eligible under this announcement?
No. The FOA is not meant to fund oncology therapeutics or other treatment-focused research. The stated scope is prevention and earlier detection rather than treatment.
Are projects focused on cancer etiology or metastasis a good fit?
No. The FOA identifies projects primarily about cancer etiology or metastasis as out of scope for this announcement.
Does this FOA fund building animal models as a primary research goal?
No. The FOA excludes the development of animal models as an end in itself. The emphasis is on prevention objectives, not foundational model-building as the primary outcome.
Are survivorship or treatment-related quality of life studies supported?
No. The FOA excludes treatment-related quality of life population-based studies, which are closer to cancer care delivery than prevention.
Who is the intended audience for this small grant program?
The program is open to both new and established investigators. It is positioned as a practical entry point for investigators who have innovative cancer prevention ideas and need modest support to demonstrate feasibility, refine methods, or generate preliminary data needed to compete for larger NIH funding later.
What disciplines or scientific areas does NCI encourage for participation?
The FOA encourages participation from a wide mix of relevant disciplines. Examples mentioned include chemoprevention, nutritional science, genetics, infectious agents, and early detection research (including biomarker development and validation).
What type of funding is this (administrative category and instrument)?
The opportunity is categorized as discretionary funding and uses the grant funding instrument.
What is the funding activity category?
It falls under a health-related funding activity category.
What CFDA number is associated with this opportunity?
This FOA is associated with CFDA 93.393, Cancer Cause and Prevention Research.
Is cost sharing or matching required?
No. The FOA indicates that cost sharing or matching is not required.
When was this funding opportunity posted and created?
The FOA was posted and created on December 13, 2010.
What were the closing dates for this FOA?
The original and current closing date listed for this FOA was December 16, 2013.
Is PAR-11-079 currently active?
No. This specific announcement was archived on January 16, 2014, meaning it is no longer active as listed under PAR-11-079.
What types of organizations are eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofits (including 501(c)(3) organizations); for-profit organizations (including small businesses and other for-profits); and multiple levels of government, such as state, county, city/township, special district governments, and certain housing authorities.
Are tribal governments or tribal organizations eligible?
Yes. The FOA includes Native American tribal governments (federally recognized) and tribal organizations among eligible applicants.
Are independent school districts eligible to apply?
Yes. Independent school districts are explicitly listed among eligible applicants.
Are minority-serving institutions eligible (HBCUs, HSIs, TCCUs, and similar)?
Yes. The FOA mentions eligibility for Alaska Native and Native Hawaiian Serving Institutions, Hispanic-Serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
Are faith-based or community-based organizations eligible?
Yes. The FOA includes faith-based or community-based organizations as eligible applicants.
Are U.S. territories or possessions eligible?
Yes. The FOA includes U.S. territories or possessions among eligible applicants.
Are non-U.S. (foreign) organizations eligible?
Yes. The eligibility list includes non-U.S. entities (foreign organizations).
Where can applicants find the full FOA text and application details?
The FOA points to the NIH Grants Guide page for PAR-11-079: http://grants.nih.gov/grants/guide/pa-files/PAR-11-079.html
Who should be contacted for technical access issues related to the FOA page?
For technical access issues, NIH lists the Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: Pilot for State specific Cross Sectional Surveillance of Persons with Rare Disorders and Longitudinal Assessment of Outcomes
Previous opportunity: WaterSMART Development of Feasibility Studies under the Title XVI Water Reclamation and Reuse Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 11 079
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 11 079) also looked into and applied for these:
| Funding Opportunity |
|---|
| Shared Instrumentation Grant Program (S10) Apply for PAR 11 081 Funding Number: PAR 11 081 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13) Apply for PAR 11 084 Funding Number: PAR 11 084 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| New Molecular Entities to Treat Substance Use Disorders (R01) Apply for RFA DA 12 001 Funding Number: RFA DA 12 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploring Human Induced Pluripotent Stem Cells for Substance Abuse Research (R21) Apply for RFA DA 11 012 Funding Number: RFA DA 11 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Personalized Genomics for Symptom Management Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R01) Apply for RFA NR 11 003 Funding Number: RFA NR 11 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Personalized Genomics for Symptom Management Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21) Apply for RFA NR 11 004 Funding Number: RFA NR 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Acute Life Threatening Conditions and Opportunities for Palliative and End of Life Care Research (R01) Apply for RFA NR 11 008 Funding Number: RFA NR 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Interdisciplinary Approaches for HIV/AIDS Risk Avoidance Decision Making in Developing Adolescents (R01) Apply for RFA NR 11 007 Funding Number: RFA NR 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Alzheimers Disease Pilot Clinical Trials (R01) Apply for PAR 11 100 Funding Number: PAR 11 100 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| U.S. India Bilateral Brain Research Collaborative Partnerships (U.S. India BRCP) (R21) Apply for PAR 11 099 Funding Number: PAR 11 099 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Increasing Opportunities in Advanced Heart Failure and Palliative Care Research (R01) Apply for RFA NR 11 006 Funding Number: RFA NR 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Reducing Health Disparities Among Minority and Underserved Children (R01) Apply for PA 11 104 Funding Number: PA 11 104 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Reducing Health Disparities Among Minority and Underserved Children (R21) Apply for PA 11 105 Funding Number: PA 11 105 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Lasker Clinical Research Scholars Program (SI2) Apply for RFA OD 11 001 Funding Number: RFA OD 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Pre Application for the 2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02) Apply for PAR 11 102 Funding Number: PAR 11 102 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| 2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (DP1) Apply for RFA DA 11 009 Funding Number: RFA DA 11 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44) Apply for RFA CA 11 002 Funding Number: RFA CA 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Predictive Animal Models for Smoking Cessation Medications (U54) Apply for RFA DA 11 014 Funding Number: RFA DA 11 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Centers for AIDS Research and Developmental Centers for AIDS Research (P30) Apply for PAR 11 108 Funding Number: PAR 11 108 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Grand Opportunity in Medications Development for Substance Related Disorders (U01) Apply for PAR 11 109 Funding Number: PAR 11 109 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 079", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.